PMID- 36544158
OWN - NLM
STAT- MEDLINE
DCOM- 20221223
LR  - 20221224
IS  - 1472-6963 (Electronic)
IS  - 1472-6963 (Linking)
VI  - 22
IP  - 1
DP  - 2022 Dec 21
TI  - A doctor-nurse-patient mobile health management system effectively controls blood 
      glucose in chinese patients with type 2 diabetes mellitus: a prospective study.
PG  - 1564
LID - 10.1186/s12913-022-08949-5 [doi]
LID - 1564
AB  - BACKGROUND: Coronavirus-2019 pandemic in China aroused increasing interest in 
      telemedicine-supported glycaemic control. We hypothesize that age might influence 
      usage and efficacy of telemedicine-supported glycaemic control. This study aims 
      to measure the effects of a doctor-nurse-patient Mobile Health Management System 
      (MHMS) for fasting plasma glucose (FPG) control in patients with type 2 diabetes 
      mellitus (T2DM). METHODS: Four hundred sixty four patients with T2DM were 
      recruited. A one-hour diabetes education provided to each patient and subsequent 
      follow-ups arranged in the 1st, 2nd, 4th, 8th, and 12th week after enrollment 
      were recorded in MHMS. The effectiveness of MHMS was defined as the proportion of 
      patients achieving FPG target (below 126 mg/dL or 7.0mml/L). RESULTS: Among the 
      enrolled 464 patients (age: 55.0 +/- 13.7 years) who were divided into three 
      groups: young (18-40 years), middle-aged (41-65 years) and elderly (> 65 years), 
      424 ones completed all follow-ups of 12 weeks. FPG decreased from 178.38 +/- 95.04 
      to 117.90 +/- 14.22 mg/dL in the young group, from 180.00 +/- 91.08 to 
      122.94 +/- 37.95 mg/dL in the middle-aged group, and from 174.24 +/- 80.64 to 
      128.88 +/- 23.4 mg/dL in the elderly group. The proportion of FPG-target-achieved 
      patients increased from 46.2 to 90.4% in the young group, from 32.6 to 82.8% in 
      the middle-aged group, and from 29.5 to 73.3% in the elderly group. The 
      proportion of FPG-target-achieved patients between three age groups were 
      statistically significant (P < 0.001). And the changes of proportion of 
      FPG-target-achieved patients at different follow-up times were statistically 
      significant (P = 0.037). Compared with the young group, the elderly group 
      achieved poorer FPG level (P = 0.032). CONCLUSION: MHMS can help patients with 
      T2DM lower FPG and improve proportion of FPG-target-achieved patients. Younger 
      patients may achieve better glycaemic control than older patients. MHMS may serve 
      multitudinous patients with T2DM to achieve adequate FPG self-management.
CI  - (c) 2022. The Author(s).
FAU - Tan, Xiaoqing
AU  - Tan X
AD  - Department of Neurology, Shenzhen Hospital, Southern Medical University, NO.1333, 
      Xinhu Road, Baoan District, Shenzhen, Guangdong, 518000, China.
AD  - School of Foreign Studies, Southern Medical University, Guangzhou, Guangdong, 
      510515, China.
FAU - Qi, Zonghai
AU  - Qi Z
AD  - Department of Neurology, Shenzhen Hospital, Southern Medical University, NO.1333, 
      Xinhu Road, Baoan District, Shenzhen, Guangdong, 518000, China.
AD  - School of Foreign Studies, Southern Medical University, Guangzhou, Guangdong, 
      510515, China.
FAU - Chen, Ling
AU  - Chen L
AD  - Nursing Department, Shenzhen Hospital, Southern Medical University, Shenzhen, 
      Guangdong, 518000, China.
FAU - Li, Dongmin
AU  - Li D
AD  - Out-patient Department, Shenzhen Sami International Medical Center, Shenzhen, 
      Guangdong, 518118, China.
FAU - Cai, Xiangyin
AU  - Cai X
AD  - Out-patient Department, Shenzhen Qianhai Free Trade Zone Hospital, Shenzhen, 
      Guangdong, 518038, China.
FAU - Song, Yi
AU  - Song Y
AD  - Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen 
      University, Shenzhen, Guangdong, 518037, China.
FAU - Liu, Yajie
AU  - Liu Y
AD  - Department of Neurology, Shenzhen Hospital, Southern Medical University, NO.1333, 
      Xinhu Road, Baoan District, Shenzhen, Guangdong, 518000, China. 244736547@qq.com.
AD  - School of Foreign Studies, Southern Medical University, Guangzhou, Guangdong, 
      510515, China. 244736547@qq.com.
LA  - eng
GR  - NO2017A020215118/Science and Technology Planning Project of Guangdong Province of 
      China/
GR  - SZSM201812047/"Sanming Project of Medicine in ShenZhen"/
PT  - Journal Article
DEP - 20221221
PL  - England
TA  - BMC Health Serv Res
JT  - BMC health services research
JID - 101088677
RN  - 0 (Blood Glucose)
SB  - IM
MH  - Aged
MH  - Middle Aged
MH  - Humans
MH  - Adult
MH  - *Diabetes Mellitus, Type 2/therapy
MH  - Blood Glucose
MH  - Prospective Studies
MH  - East Asian People
MH  - China
MH  - Fasting
PMC - PMC9768766
OTO - NOTNLM
OT  - Blood glucose
OT  - Glycaemic control
OT  - Self-management
OT  - Telemedicine
OT  - Type-2 diabetes mellitus
COIS- The authors declare that they have no competing interests.
EDAT- 2022/12/22 06:00
MHDA- 2022/12/24 06:00
PMCR- 2022/12/21
CRDT- 2022/12/21 23:46
PHST- 2022/08/09 00:00 [received]
PHST- 2022/12/09 00:00 [accepted]
PHST- 2022/12/21 23:46 [entrez]
PHST- 2022/12/22 06:00 [pubmed]
PHST- 2022/12/24 06:00 [medline]
PHST- 2022/12/21 00:00 [pmc-release]
AID - 10.1186/s12913-022-08949-5 [pii]
AID - 8949 [pii]
AID - 10.1186/s12913-022-08949-5 [doi]
PST - epublish
SO  - BMC Health Serv Res. 2022 Dec 21;22(1):1564. doi: 10.1186/s12913-022-08949-5.